Trial Profile
Post Marketing Surveillance in Japan on Long Term Drug Use of TRADIANCE Combination Tablets AP and BP in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2023
Price :
$35
*
At a glance
- Drugs Empagliflozin/linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 May 2021 Status changed from active, no longer recruiting to completed.
- 14 Jan 2021 Planned primary completion date changed from 31 Dec 2020 to 30 Apr 2021.
- 18 Mar 2020 Status changed from recruiting to active, no longer recruiting.